Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.89 +0.01 (+0.09%)
At close: Oct 1, 2026 · 4:00 PM EDT

Drugs Made In America Acquisition (DMAA) Operating Expenses (2025 - 2026)

Updated

Drugs Made In America Acquisition's Operating Expenses was $136,934 in Q2 2026, up 3.8% from $131,919 a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) Operating Expenses (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Drugs Made In America Acquisition's Operating Expenses was $2.62 million through Jun 30, 2026; for FY2025, it was $2.82 million, up 906.3% from FY2024.

  • In earlier years, Operating Expenses was $279,845 in FY2024.
  • Quarterly Operating Expenses has moved between $131,919 (Q2 2025) and $2.09 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 BlackRock 164.13 Bn 110.49 Bn - 4.62 Bn
2 Spdr Gold Trust 133.82 Bn -424.18 Bn - 149.76 Mn
3 Blackstone 84.08 Bn 79.01 Bn - 2.38 Bn
4 Brookfield 82.97 Bn -82.41 Bn 4.47 Bn 14.94 Bn
5 Kkr 81.05 Bn 47.53 Bn - 5.41 Bn
6 Brookfield Asset Management 71.64 Bn 67.88 Bn - 659.00 Mn
7 Apollo Global Management 65.67 Bn 3.35 Bn 10.56 Bn 8.74 Bn
8 Wheaton Precious Metals 61.89 Bn 57.32 Bn 687.86 Mn 133.83 Mn
9 Franco Nevada 46.13 Bn 43.49 Bn 451.00 Mn 7.80 Mn
10 Drugs Made In America Acquisition 335.55 Mn 335.55 Mn - 136,934.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 136,934.00
Dec 31, 2025 2.09 Mn
Sep 30, 2025 263,703.00
Jun 30, 2025 131,919.00
Mar 31, 2025 330,925.00
API Access

Drugs Made In America Acquisition Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=DMAA&period=max&api_key=YOUR_API_KEY